Literature DB >> 1375856

Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin.

H Bachelard1, S M Gardiner, P A Kemp, T Bennett.   

Abstract

1. The regional haemodynamic effects of i.v. bolus injections of bradykinin (0.05 or 0.5 nmol), cholecystokinin (0.175 or 1.75 nmol), substance P (0.01 or 0.1 nmol) and calcitonin gene-related peptide (0.05 or 0.5 nmol) were assessed in conscious, adult Long Evans rats that had been treated neonatally with either capsaicin (50 mg kg-1, s.c.) or vehicle. 2. In vehicle-treated rats, both doses of bradykinin were without effect on blood pressure, but caused tachycardia and hindquarters vasodilatation. Moreover, after the higher dose there were dilatations in the renal and superior mesenteric vascular beds. In capsaicin-treated rats the hindquarters vasodilator effects elicited by both doses of bradykinin were significantly reduced, while the tachycardia and responses in the renal and superior mesenteric vascular beds were unchanged. 3. In vehicle-treated rats, cholecystokinin caused dose-dependent increases in blood pressure accompanied by renal, superior mesenteric and hindquarters vasoconstriction followed, after the higher dose, by a hindquarters vasodilatation. The lower dose produced a tachycardia, while there was a bradycardia followed by a tachycardia after the higher dose. In capsaicin-treated rats, the pressor response, as well as the renal vasoconstrictor effects of cholecystokinin, were greater than in vehicle-treated rats, while the heart rate, superior mesenteric or hindquarters responses were not different. 4. In vehicle-treated rats, substance P produced a dose-dependent depressor response and tachycardia accompanied by dilatations in the renal and hindquarters vascular beds and constriction in the superior mesenteric vascular bed. In capsaicin-treated rats, the responses to the lower dose of substance P were not different from those in vehicle-treated rats, while the depressor response to the higher dose of substance P was slightly less than in vehicle-treated rats and the renal vasodilatation was absent.5. In vehicle-treated rats, calcitonin gene-related peptide caused dose-dependent hypotensive and tachycardic effects associated with dilatations in renal and hindquarters vascular beds and a constriction in the superior mesenteric vascular bed. After the higher dose, the renal vasodilatation was followed by a modest vasoconstriction. In capsaicin-treated rats, the depressor responses to both doses of calcitonin generelated peptide were slightly more prolonged than in vehicle-treated animals, whereas the heart rate and renal and mesenteric vascular conductance changes were not significantly different. However, there was a more sustained hindquarters vasodilator response to the higher dose of calcitonin gene-related peptide in the capsaicin-treated rats.6. The results suggest that peripheral, capsaicin-sensitive neurones are involved in the cardiovascular responses to exogenous bradykinin and cholecystokinin in conscious rats. It does not appear that the extent of involvement of these neurones is underestimated on account of development of marked supersensitivity to the peptides they normally release, since responses to such peptides (e.g. substance P and calcitonin gene-related peptide) are relatively normal in capsaicin-treated rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375856      PMCID: PMC1908627          DOI: 10.1111/j.1476-5381.1992.tb14235.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN.

Authors:  W FELDBERG; G P LEWIS
Journal:  J Physiol       Date:  1964-05       Impact factor: 5.182

2.  Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart.

Authors:  P Geppetti; C A Maggi; F Perretti; S Frilli; S Manzini
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

3.  Capsaicin pretreatment attenuates multiple responses to cholecystokinin in rats.

Authors:  M J McCann; J G Verbalis; E M Stricker
Journal:  J Auton Nerv Syst       Date:  1988-09

4.  Regional haemodynamic effects of human alpha- and beta-calcitonin gene-related peptide in conscious Wistar rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

5.  The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the rat and cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin.

Authors:  P W Mantyh; S P Hunt
Journal:  Brain Res       Date:  1985-04-22       Impact factor: 3.252

6.  Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin.

Authors:  J M Lundberg; A Franco-Cereceda; X Hua; T Hökfelt; J A Fischer
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

7.  Specific receptor and cardiovascular effects of calcitonin gene-related peptide.

Authors:  S Sigrist; A Franco-Cereceda; R Muff; H Henke; J M Lundberg; J A Fischer
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

Review 8.  The sensory-efferent function of capsaicin-sensitive sensory neurons.

Authors:  C A Maggi; A Meli
Journal:  Gen Pharmacol       Date:  1988

9.  Regional hemodynamic effects of calcitonin gene-related peptide.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Am J Physiol       Date:  1989-02

10.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

View more
  4 in total

1.  Characterization of the endokinins: human tachykinins with cardiovascular activity.

Authors:  Nigel M Page; Nicola J Bell; Sheila M Gardiner; Isaac T Manyonda; Kerensa J Brayley; Philip G Strange; Philip J Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

2.  Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.

Authors:  J Damas; C Hallet; P J Lefebvre
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rats.

Authors:  Xavier Charest-Morin; Hélène Bachelard; Melissa Jean; Francois Marceau
Journal:  PeerJ       Date:  2017-01-18       Impact factor: 2.984

4.  In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases.

Authors:  Mélissa Jean; Lajos Gera; Xavier Charest-Morin; François Marceau; Hélène Bachelard
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.